Semaglutide Injections
Provider-managed weekly injection. The same compounded GLP-1 as the big-brand competitors — with bilingual care, no insurance, no dose upcharges.
- ✓ Bilingual care, every visit (EN · ES)
- ✓ −5″ off the waist in trials¹
Weight Loss · GLP-1 Program
In clinical trials, the active medication tirzepatide reduced body weight by up to 22%. REMEVi connects you with a licensed provider and ships compounded tirzepatide directly to your door. $249 for your first month ($130 welcome discount applied automatically at checkout), then $379/month — or as low as $269/mo on a 52-week plan ($339/mo 12-week). All-inclusive.
Compounded tirzepatide is not FDA-approved and is not a generic version of Mounjaro® or Zepbound®. Your provider prescribes a compounded preparation only when they determine it offers a meaningful clinical difference for you — such as personalized dose titration. Trial results are for the active medication, not REMEVi outcomes.
The science
Tirzepatide is a dual GIP/GLP-1 receptor agonist that mimics two natural hormones to regulate appetite, metabolism, and blood sugar.
Signals the brain to eat less and feel full longer.
Slows food movement through the digestive system.
Regulates glucose and reduces cravings via GIP + GLP-1.
Activates two receptors for greater weight loss than GLP-1 alone.
Treatment plan
Provider-supervised dose escalation every 4 weeks to maximize results and minimize side effects.
Weeks 1–4
2.5 mg
Starter dose weekly
Weeks 5–8
5 mg
First therapeutic dose
Weeks 9–12
7.5 mg
Increased every 4 weeks
Weeks 13–24
10–15 mg
Titrate to maintenance
Injection method
Subcutaneous (under the skin)
Frequency
Once per week
Provider check-ins
Monthly dose adjustments
Timeline
Full 24-week program
What to expect
Weight loss milestones and what patients typically experience at each phase.
Weeks 1–4
Noticeable decrease in hunger and food cravings begins.
Weeks 5–12
Body weight reduction of 5–10% is common at this phase.
Weeks 13–24
Total body weight loss in clinical trials (SURMOUNT-1).
Ongoing
Maintenance dosing available to preserve results long-term.
Results vary based on adherence, diet, exercise, and individual metabolism. Your REMEVi licensed provider will monitor your progress and adjust dosing as needed.
All-inclusive
Unlike Hims, Ro, and Medvi — there are no hidden lab fees or add-on charges.
Prescription from a board-certified US licensed provider who reviews your full health history.
Compounded tirzepatide from a 503B-accredited pharmacy under strict quality control.
Medication shipped directly to your door in unmarked packaging. Free every month.
Care team available in English and Spanish with a 2-hour response target.
Regular check-ins with your care team to adjust dosage and monitor your progress.
REMEVi is a LegitScript-certified telehealth platform you can trust.
Real cost comparison
Brand-name Zepbound runs $299–$449/mo and rises as you titrate up. REMEVi compounded tirzepatide is $249 your first month ($130 welcome discount applied automatically), then one flat $379 at every dose — with no membership fee.
Representative advertised prices as of June 2026, standard dosing. Your price won’t climb with your dose. REMEVi compounded medications are not FDA-approved.
Sources: MEDVi, Zepbound (LillyDirect)
One flat price at every dose. Most weight-loss programs raise your price every time your dose goes up — REMEVi never does. Visit, medication, coaching and shipping — one number. No separate membership fee. (Many programs add a $79–$149/mo membership on top of the medication price.)
Provider-managed weekly injection. The same compounded GLP-1 as the big-brand competitors — with bilingual care, no insurance, no dose upcharges.
Daily oral semaglutide. Same clinical oversight, same bilingual care — without the needle.
Dual-agonist tirzepatide. The strongest average loss in the GLP-1 category — provider-managed, bilingual care.
¹ Clinical-trial results for semaglutide (STEP-1, NEJM 2021) and tirzepatide (SURMOUNT-1, NEJM 2022) — the active medications in REMEVi protocols, not REMEVi outcomes or guarantees. Compounded preparations are not FDA-approved and have not been studied as finished products. Individual results vary.
Most programs charge more as your dose increases. At REMEVi, your price stays flat at every dose — with no separate membership fee on top of the medication price.
Compare with Semaglutide What compounded tirzepatide costs Compounded Zepbound alternative
REMEVi's semaglutide is compounded by a 503B outsourcing facility registered with the FDA — the same regulatory tier hospitals use. Compounded medications are not FDA-approved finished drug products; they are prepared under the 503A or 503B framework to USP <797> sterility standards and prescribed by a licensed provider in your state who will review the risks, benefits, and considerations with you.
FAQ
Tirzepatide is a dual GIP/GLP-1 receptor agonist medication approved for weight management. It works by reducing appetite and improving blood sugar regulation.
REMEVi prescribes compounded tirzepatide, which is not the same as, and is not a generic version of, Mounjaro® or Zepbound® (FDA-approved finished drug products manufactured by Eli Lilly). Compounded tirzepatide is a non-FDA-approved preparation prepared by a state-licensed compounding pharmacy under an individual prescription from a licensed US provider. Compounded preparations have not been clinically studied as finished products. Your licensed provider will review risks, benefits, and considerations with you before prescribing.
Your first month is $249 ($130 welcome discount applied automatically at checkout). After that it's $379/month on the monthly plan, $339/mo on the 12-week plan, or as low as $269/mo on the 52-week plan. All plans are all-inclusive — no hidden fees.
Clinical trials (SURMOUNT-1) showed tirzepatide at the highest dose produced up to 22% body weight loss, generally outperforming semaglutide trials. Individual results vary.
Most patients notice appetite changes in the first 2–4 weeks. Meaningful weight loss typically becomes visible by weeks 8–12.
Yes. Your REMEVi licensed provider can evaluate a transition during your consultation.
The secure medical intake takes about 5 minutes. Clinical review within 24 hours. Medication shipped free.
See if you qualify — $249 first monthWhat GLP-1 is, how it works, what to expect, and nutrition tips — in English and Spanish. Free, straight to your inbox.
No spam. Unsubscribe anytime.
Free · no card required